PHARMACOKINETIC STUDIES ON 4'-CHLORO-5-METHOXY-3-BIPHENYLYLACETIC ACID AND ITS METABOLITES IN RATS AND HUMANS

スポンサーリンク

概要

• 論文の詳細を見る

• The pharmacokinetics of 4'-chloro-5-methoxy-3-biphenylylacetic acid (DKA-9) and its metabolites were studied in rats and humans. Appropriate equations describing models for rats and humans were fitted to the plasma (and urine) data using a non-linear least-squares analysis. 1. Rats : After intravenous administration (2.5 mg/kg) of ^<14>C-DKA-9 to rats, the concentration of DKA-9 and 5-carboxymethyl-4'-chloro-3-biphenylyl hydrogen sulfate (DKA-24S) in plasma were both described by the two compartment model ; the half lives of hybrid rate constants [(t_<1/2>) α and (t_<1/2>) β] and the volume of the central compartment were 0.424,2.91 hr and 0.101 L/kg for DKA-9,and 0.295,8.07 hr and 0.129 L/kg for DKA-24S, respectively. Urinary excretion (% of dose) of radioactivity was 87.8±1.3% (mean±S.D., n=3) and 99% of which corresponded to DKA-24S. However, the concentration of 4'-chloro-5-hydroxy-3-biphenylylacetic acid (DKA-24), which is the precursor of DKA-24S, was found to be negligible in most of plasma, urinary, and fecal samples, therefore, this metabolite was neglected in the kinetic study. 2. Humans : When DKA-9 was administered orally to seven healthy male subjects, DKA-9 absorption and disposition did not virtually show a dose-dependency at doses of 42.8 and 85.5 mg : DKA-9 was absorbed from a gastro-intestinal tract with the half life [(t_<1/2>)_<ka>] of 0.525±0.129 hr (n=7) after the lag time (t_<lag>) of 0.526±0.266 hr ; the maximum concentration (C_<max>) of DKA-9 was 3.1±0.1 (n=3) and 5.5±0.4 μg/ml (n=4), and the area under the DKA-9 plasma concentration-time curve in 0-8 hr ([AUC]_<0-8hr>) was 6.85±0.54 and 13.1±0.9 μg・hr/ml after administration of 42.8 and 85.5 mg, respectively. Urinary excretion of DKA-9 and its metabolites (% of dose, n=4) were : DKA-9 (≒0), DKA-24 (≒0), 4'-chloro-5-methoxy-3-biphenylylacetyl β-D-glucopyranosiduronic acid (DKA-9G) (60.1±6.0%), 4'-chloro-5-hydroxy-3-biphenylylacetyl β-D-glucopyranosiduronic acid (DKA-24G) (8.1±0.4%), DKA-24S (13.9±0.4%), 5-carboxymethyl-4'-chloro-3-biphenylyl β-D-glucopyranosiduronic acid (DKA-24OG) (6.5±0.6%), and 2-(4'-chloro-5-methoxy-3-biphenylyl)-2-hydroxyacetic acid (αOH-DKA-9) (1.3±1.2%). Urinary excretion rate constants of DKA-9G and DKA-24G were found to be much greater in magnitude than those of DKA-24S and DKA-24OG, which suggests that acylglucuronides could be more easily excreted from plasma due to a lesser degree of plasma protein binding.

著者

• MORINO AKIRA

  Research Laboratories, Nippon Shinyaku Co., Ltd.

• Morino Akira

  Research Laboratories Nippon Shinyaku Co. Ltd.

• Sugiyama Makoto

  Research Laboratories Nippon Shinyaku Co. Ltd.

• IZUMI SHOGO

  Research Laboratories, Nippon Shinyaku Co., Ltd.

関連論文

• Effect of α-Cyclodextrin on Thermostability of Glucoamylase(Biological Chemistry)
• Isolation of 2-Amino-2-deoxy-D-mannitol from Culture Broth of Streptomyces species(Microbiology & Fermentation Industry)
• STUDIES ON THE ABSORPTION OF SODIUM GUAIAZULENE-3-SULFONATE. I
• KINETIC STUDY ON PHARMACOLOGIC RESPONSE AND DRUG DISPOSITION IN THE PRESENCE OF ACTIVE METABOLITES : APPLICATION TO CAMAZEPAM
• RELATION BETWEEN TIME COURSES OF PHARMACOLOGICAL EFFECTS AND OF PLASMA LEVELS OF CAMAZEPAM AND ITS ACTIVE METABOLITES IN RATS
• STUDIES ON THE ABSORPTION OF SODIUM GUAIAZULENE-3-SULFONATE. II. ABSORPTION MECHANISM FROM NASAL AND INTESTINAL MEMBRANE
• CORRELATION BETWEEN ANTI-INFLAMMATORY ACTIVITY AND PERIPHERAL DRUG IN RAT AFTER ADMINISTRATION OF BIPHENYLYLACETIC ACID DERIVATIVES
• PHARMACOKINETIC STUDIES ON 4'-CHLORO-5-METHOXY-3-BIPHENYLYLACETIC ACID AND ITS METABOLITES IN RATS AND HUMANS
• Enzymatic Preparation of N-Substituted 4-(O-α-D-Glucopyranosylmoranoline Derivatives

スポンサーリンク